Cargando…
SDZ 280-446, a novel semi-synthetic cyclopeptolide: in vitro and in vivo circumvention of the P-glycoprotein-mediated tumour cell multidrug resistance.
SDZ 280-446 is a semi-synthetic derivative of a natural cyclic peptolide. Its ability to sensitise in vitro tumour cells whose resistance is due to P-glycoprotein-mediated anticancer-drug efflux was shown using four different pairs of parental drug-sensitive (Par-) and multidrug-resistant (MDR-) cel...
Autores principales: | Loor, F., Boesch, D., Gavériaux, C., Jachez, B., Pourtier-Manzanedo, A., Emmer, G. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1992
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1977342/ https://www.ncbi.nlm.nih.gov/pubmed/1346365 |
Ejemplares similares
-
Circumvention of Atypical Multidrug Resistance with Tumor Necrosis Factor
por: Cimoli, Guido, et al.
Publicado: (1994) -
Enhanced oral bioavailability of paclitaxel in mice treated with the P-glycoprotein blocker SDZ PSC 833.
por: van Asperen, J., et al.
Publicado: (1997) -
Modulation of Multidrug Resistance by SDZ PSC 833 in Leukemic and Solid‐tumor‐bearing Mouse Models
por: Watanabe, Toru, et al.
Publicado: (1996) -
Inhibitory Effects of a Cyclosporin Derivative, SDZ PSC 833, on Transport of Doxorubicin and Vinblastine via Human P‐Glycoprotein
por: Kusunoki, Nobuya, et al.
Publicado: (1998) -
In vitro antitumour activity of the novel imidazoisoquinoline SDZ 62-434.
por: Brunton, V. G., et al.
Publicado: (1993)